Quick answers
- Is there a shortage of Desmopressin acetate (desmopressin acetate trihydrate)?
- The FDA drug shortage list shows “Current shortage” for a product of this medicine (updated October 15, 2026). Ask your pharmacist about alternatives.
- Has Desmopressin acetate (desmopressin acetate trihydrate) been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started April 8, 2026 (Class II). A recall usually concerns specific lots, not every product.
- Who makes Desmopressin acetate (desmopressin acetate trihydrate)?
- 1 company lists prescription products of Desmopressin acetate (desmopressin acetate trihydrate) in the FDA NDC Directory, including Apotex Corp..
What Desmopressin acetate (desmopressin acetate trihydrate) is used for
We did not find an “Indications and Usage” section in the FDA labels for this medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Forms and how it is given
| Dosage forms | Tablet · Spray |
|---|---|
| Route | Oral · Nasal |
| Prescription products | 2 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| desmopressin acetate trihydrate 0.1 mg tablet | Generic | $0.2352 per tablet |
| desmopressin acetate trihydrate 10 ug spray | Generic | $10.53 per mL |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Apotex Corp.2 products
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (2)
- ANDA076703Apotex · January 27, 2005
- ANDA077414Apotex · March 7, 2006
Shortage status
Current shortage · updated October 15, 2026 · first posted March 12, 2021
| Product | Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0) |
|---|---|
| Availability | Limited Availability |
| Reason given | Delay in shipping of the drug |
| Company | Apotex Corp. |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
April 8, 2026 · Class II · Ongoing · D-0510-2026
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0 — Apotex Corp.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| FDA labels (SPL) | 0 |
|---|---|
| FDA applications | 2 ANDA |
| Active ingredients (FDA) | DESMOPRESSIN ACETATE TRIHYDRATE |
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →